Your browser doesn't support javascript.
loading
Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients.
Johnson, Tanner M; Howard, Amanda H; Miller, Matthew A; Allen, Lorna L; Huang, Misha; Molina, Kyle C; Bajrovic, Valida.
Afiliación
  • Johnson TM; Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.
  • Howard AH; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
  • Miller MA; Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.
  • Allen LL; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
  • Huang M; Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.
  • Molina KC; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
  • Bajrovic V; Department of Medicine-Infectious Diseases, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.
Open Forum Infect Dis ; 8(7): ofab294, 2021 Jul.
Article en En | MEDLINE | ID: mdl-34262988
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos